Julian G Hurdle

11PUBLICATIONS
18CO-AUTHORS
Medical infection agents (incl. prions)Food engineeringRehabilitation engineeringInfectious agentsEndodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 03, 2026
Case Commentary: Emergence of clinically relevant fidaxomicin-resistant Clostridioides difficile strains.

|Dec 17, 2025
Development of a high-throughput screening platform for C. difficile toxin synthesis inhibitors unveils meclizine as an antivirulence agent.

Ravi K R Marreddy, Nghi Nguyen, Chetna Dureja

|Feb 21, 2025
The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae.

Jacob K McPherson, Julian G Hurdle, Matthew L Baker

|Nov 08, 2024
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes.

Taryn A Eubank, Chetna Dureja, Anne J Gonzales-Luna

|Nov 06, 2024
Fidaxomicin resistance in Clostridioides difficile: a systematic review and predictive modeling with RNA polymerase binding sites.

ThanhPhuong M Le, Taryn A Eubank, Ann M McKelvey

|Apr 10, 2024
Evaluation of Fusobacterium nucleatum Enoyl-ACP Reductase (FabK) as a Narrow-Spectrum Drug Target.

Jacob T Rutherford, Kristiana Avad, Chetna Dureja

Pageof 2

Frequent Collaborators

5 joint publications

Kevin W Garey

3 joint publications

Dianqing Sun

3 joint publications

Kirk E Hevener

2 joint publications

Allan M Prior